Cytek Biosciences Reports First Quarter 2022 Financial Results

Go back to Cytek Biosciences Reports First Quarter 2022 Financial Results
(NASDAQ: CTKB) Delayed: 5.43 --0 (-0%)
Previous Close $5.43    52 Week High $ 
Open $5.43    52 Week Low $ 
Day High $5.43    P/E N/A 
Day Low $5.43    EPS $ 
Volume 3